Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide

<div>Comparative overall survival outcomes according to CRP/Alb ratio: &lt;0.75 (solid line) and ≥0.75 (dotted line).</div>

International Journal of Inflammation

fig2

Figure 2

Figure 2: Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide 

Figure 2 | Prognostic Value of C-Reactive Protein to Albumin Ratio in Glioblastoma Multiforme Patients Treated with Concurrent Radiotherapy and Temozolomide 